Position
Google scholar page: https://scholar.google.com/citations?user=TqI0uDsAAAAJ&hl=en
Research Gate: https://www.researchgate.net/profile/Paul Nugent2
Outline Biography
I am a graduate of the University of Cape Town (first degree and first postgraduate degree, 1980-83) and holder of a Masters and a doctorate from the School of Oriental and African Studies (SOAS) in London. I held a temporary lectureship in Comparative Politics at the University of Keele in 1987/88, before taking up a Lectureship in African History at Edinburgh. I was promoted to Reader in 2003 and Professor in 2005. I was the Director of the Centre of African Studies for ten years and was formerly co-Director of the Edinburgh International Development Centre.
Denmark changes travel advice: These are the new coronavirus guidelines thelocal.dk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelocal.dk Daily Mail and Mail on Sunday newspapers.
IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration
IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration
SILVER SPRING, Md. (March 3, 2021) The nonprofit International Partnership for Microbicides (IPM) announced today that the US Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the monthly dapivirine vaginal ring, designed to reduce the risk of HIV-1 infection through vaginal sex.
Made of flexible silicone, the investigational product releases an antiretroviral drug (ARV) called dapivirine over the course of one month. Women can insert and replace the ring themselves. IPM designed the ring to offer women a discreet and long-acting HIV prevention choice that they can control themselves.